Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M.A. Khamashta, G.R.V. Hughes.
Antiphospholipid antibodies and antiphospholipid syndrome.
Curr Op Rheumatol, 7 (1995), pp. 389-394
[3.]
R.A. Asherson, R. Cervera, R.G. Lahita.
Latent, incomplete or lupus at all?.
J Rheumatol, 18 (1991), pp. 1783-1786
[4.]
R.A. Asherson, J.C. Piette, R. Cervera.
“Primary”, “secondary”, “catastrophic”, and other variants of the antiphospholipid syndrome.
The antiphospholipid syndrome,
[5.]
R.A. Asherson, R. Cervera.
The antiphospholipid syndrome: a syndrome in evolution.
Ann Rheum Dis, 51 (1992), pp. 147-150
[6.]
R. Cervera, J. Font, A. López-Soto, F. Casals, L. Pallarés, A. Bové, et al.
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
Ann Rheum Dis, 49 (1990), pp. 109-113
[7.]
J.C. Piette, B. Weschler, C. Francès, P. Godeau.
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria.
J Rheumatol, 19 (1992), pp. 1835-1837
[8.]
A. Brucato, F. Baudo, M. Barberis, R. Redaelli, G. Casadei, F. Allegri, et al.
Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J.
Rheumatol, 21 (1994), pp. 942-944
[9.]
A.A. Turjanski, J.D. Finkielman, M. Vázquez-Blanco.
Isolated tricuspid valve disease in antiphospholipid syndrome.
Lupus, 8 (1998), pp. 474-476
[10.]
E. Cucurull, J. Ordi Ros, M. Murtra, L. Mellibovsky, R. Orriols, M. Vilardell.
Tromboendarterectomía pulmonar en un paciente con síndrome antifosfolípido primario.
Med Clin (Barc), 106 (1996), pp. 498-500
[11.]
M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, G.R.V. Hughes.
The management of thrombosis in the antiphospholipidantibody syndrome.
N Engl J Med, 332 (1995), pp. 993-997
[12.]
F.J. Muñoz-rodríguez, J. Font, R. Cervera, J.C. Reverter, D. Tàssies, G. Espinosa, et al.
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome.
Semin Arthritis Rheum, 29 (1999), pp. 182-190
[13.]
S. Krnic-Barrie, C.R. O'Connor, S.W. Looney, S.S. Pierangeli, E.N. Harris.
A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis.
Arch Intern Med, 157 (1997), pp. 2101-2108
[14.]
J.L. Vianna, M.A. Khamashta, J. Ordi-ros, J. Font, R. Cervera, A. López- Soto, et al.
Comparison of the primary and secondary antiphospholipid syndrome: an European multicenter study of 114 patients.
Am J Med, 96 (1994), pp. 3-9
[15.]
D. Alarcón-Segovia, M.E. Pérez-Vázquez, A.R. Villa, C. Drenkard, J. Cabiedes.
Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus.
Semin Arthritis Rheum, 21 (1992), pp. 275-286
[16.]
R.A. Asherson, T.W. Higenbottam, A.T. Dinh Xuan, M.A. Khamashta, G.R.V. Hughes.
Pulmonary hypertension in a lupus clinic: experience with twenty-four patients.
J Rheumatol, 17 (1990), pp. 1292-1298
[17.]
T. Koike, A. Tsusumi.
Pulmonary hypertension and the antiphospholipid syndrome.
Intern Med, 34 (1995), pp. 938
[18.]
T. Kunieda.
Antiphospholipid syndrome and pulmonary hypertension.
Intern Med, 35 (1996), pp. 842-843
[19.]
J.C. Piette, B.J. Hunt.
Pulmonary hypertension and antiphospholipid antibodies.
Hughes syndrome. Antiphospholipid syndrome,
[20.]
K.M. Moser, W.R. Auger, P.F. Fedullo.
Chronic major-vessel thromboembolic pulmonary hypertension.
Circulation, 81 (1990), pp. 1735-1743
[21.]
S.W. Jamieson, W.R. Auger, P.F. Fedullo, R.N. Channick, J.M. Kriett, R.Y. Tarazi, et al.
Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period.
J Thorac Cardiovasc Surg, 106 (1993), pp. 116-127
[22.]
J. Sandoval, M.C. Amigo, R. Barragán, R. Izaguirre, P.A. Reyes, M.L. Martínez- Guerra, et al.
Primary antiphospholipid syndrome presenting as chronic thromboembolic hypertension. Treatment with thromboendarterectomy.
J Rheumatol, 23 (1996), pp. 772-775
[23.]
R.A. Asherson, C.G. Mackworth-Young, M.L. Boey, R.G. Hull, A. Saunders, A.E. Gharavi, et al.
Pulmonary hypertension in systemic lupus erythematosus.
Br Med J, 287 (1983), pp. 1024-1025
[24.]
L.S. Tam, E.K. Li.
Succesful treatment with immunosupression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome.
Lu- pus, 7 (1998), pp. 495-497
[25.]
R.A. Asherson, D. Hackett, A.E. Gharavi, E.N. Harris, H.G. Kennedy, G.R.V. Hughes.
Pulmonary hypertension in systemic lupus erythematosus. A report of three cases.
J Rheumatol, 12 (1986), pp. 416-420
[26.]
C.G. Mackworth-Young, A.E. Ghavari, M.L. Boey, G.R.V. Hughes.
Portal and pulmonary hypertension in a case of systemic lupus erythematosus: possible relationship with clotting abnormalities.
Eur J Rheumatol Inflamm, 7 (1984), pp. 71-74
[27.]
E.N. Anderson, M.R. Ali.
The lupus anticoagulant, pulmonary thromboembolism and fatal pulmonary hypertension.
Ann Rheum Dis, 43 (1984), pp. 760-763
[28.]
R.A. Asherson, C.N. Oakley.
Pulmonary hypertension and systemic lupus erythematosus.
J Rheumatol, 13 (1986), pp. 1-5
[29.]
R.A. Asherson, S.H. Morgan, E.N. Harris, A.E. Gharavi, G.R.V. Hughes, A.B. Millar.
Pulmonary hypertension and chronic cutaneous lupus erytematosus: association with lupus anticoagulant.
Arthritis Rheum, 28 (1985), pp. 118
[30.]
P. Hainaut, E. Lavanne, J.M. Magy, G. Lebacq.
Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease.
Clin Rheumatol, 5 (1986), pp. 96
[31.]
R.A. Asherson, M.A. Khamashta, J. Ordi-ros, R.H.W. Derksen, S.J. Machin, J. Barquinero, et al.
The “primary” antiphospholipid syndrome: major clinical and serological features.
Medicine (Baltimore), 68 (1989), pp. 366-374
[32.]
J. Font, A. López-Soto, R. Cervera, J. Balasch, L. Pallarés, M. Navarro, et al.
The “primary” antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.
Autoimmunity, 9 (1991), pp. 69-75
[33.]
P. Jeffrey, R.A. Asherson, P.J. Rees.
Recurrent deep venous thrombosis and thromboembolic pulmonary hypertension in the “primary” antiphospholipid syndrome.
Clin Exp Rheumatol, 7 (1989), pp. 567-569
[34.]
D. Alarcón-Segovia, J. Sánchez-Guerrero.
Primary antiphospholipid syndrome.
J Rheumatol, 16 (1989), pp. 482-488
[35.]
H. Nagai, K. Yasuma, T. Katsuki, A. Shimakura, K. Usuda, Y. Nakamura, et al.
Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report.
Angiology, 48 (1997), pp. 138-147
[36.]
M. Petri, M. Rheinschmidt, Q. Whiting-O'Keefe, D. Hellmann, L. Corash.
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.
Ann Intern Med, 106 (1987), pp. 524-531
[37.]
M. Miyata, K. Suzuki, F. Sakuma, H. Watanabe, S. Kaise, T. Nishimaki, et al.
Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus.
Int Arch Allergy Immunol, 100 (1993), pp. 351-354
[38.]
M.E. Luchi, R.A. Asherson, R.G. Lahita.
Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis.
Tenn Med, 89 (1996), pp. 166-168
[39.]
J. De la Mata, M.A. Gómez-Sánchez, M. Aranzana, J.J. Gómez-reino.
Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases.
Arthritis Rheum, 37 (1994), pp. 1528-1533
[40.]
P. Cacoub, R. Dorent, P. Nataf, A. Carayon, M. Riquet, E. Noe, et al.
Endothelin-1 in the lungs of patients with pulmonary hypertension.
Cardiovasc Res, 33 (1997), pp. 196-200
[41.]
T. Atsumi, M.A. Khamashta, R.S. Haworth, G. Brooks, O. Amengual, K. Ichikawa, et al.
Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role of endothelin-1.
Arthritis Rheum, 41 (1998), pp. 800-807
[42.]
T. Yoshio, J. Masuyama, M. Sumiya, S. Minota, S. Kano.
Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
J Rheumatol, 21 (1994), pp. 2058-2063
[43.]
T. Yoshio, J. Masuyama, A. Mimori, A. Takeda, S. Minota, S. Kano.
Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus.
Ann Rheum Dis, 54 (1995), pp. 361-365
[44.]
S.G. Haworth.
Primary pulmonary hypertension.
J R Coll Physicians Lond, 32 (1998), pp. 187-190
[45.]
W.R. Auger, P. Permpikul, K.M. Moser.
Lupus anticoagulant heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report.
Am J Med, 99 (1995), pp. 392-396
[46.]
M. Ando, S. Takamoto, Y. Okita, R. Matsukawa, N. Nakanishi, S. Kyotani, et al.
Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients.
Ann Thorac Surg, 66 (1998), pp. 1919-1924
[47.]
M. Humbert, O. Sánchez, M. Fartoukh, J.L. Jagot, O. Sitbon, G. Simmonneau.
Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).
Chest, 114 (1998), pp. 80-82
[48.]
H. Groen, H. Boostsma, D.S. Postma, C.G.M. Kallanberg.
Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.
J Rheumatol, 20 (1993), pp. 1055-1057
[49.]
E. Gertner, J.T. Lie.
Pulmonary capillaritis, alveolar haemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome.
J Rheumatol, 20 (1993), pp. 1224-1228
[50.]
R.A. Asherson.
The catastrophic antiphospholipid syndrome.
J Rheumatol, 19 (1992), pp. 508-512
[51.]
M. Maggiorini, A. Knoblauch, J. Schneider, E.W. Russi.
Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome.
Eur Respir J, 10 (1997), pp. 727-730
[52.]
R.A. Asherson, M. Ridley, C.D.M. Fletcher, G.R.V. Hughes.
Systemic lupus erythematosus, pulmonary hypertension, and adult respiratory distress syndrome (ADRS).
Clin Exp Rheumatol, 6 (1988), pp. 301-304
[53.]
A.P. Adonopoulos.
Adult respiratory distress syndrome: an unrecognized premortem event in systemic lupus erythematosus.
Br J Rheumatol, 30 (1991), pp. 346-348
[54.]
S. Ghosh, H.D. Walters, J.H. Joist, T.G. Osborn, T.L. Moore.
Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome.
J Rheumatol, 20 (1993), pp. 1406-1408
[55.]
S.B. Ingram, S.H. Goodnight, R.M. Bennett.
An unusual syndrome of a devastating non-inflammatory vasculopathy associated with anticardiolipin antibodies: a report of two cases.
Arthritis Rheum, 30 (1987), pp. 1167-1172
[56.]
J.E. Kerr, R. Poe, Z. Kramer.
Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy.
Chest, 112 (1997), pp. 1707-1710
[57.]
A. Argento, R.J. DiBenedetto.
ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome.
Chest, 113 (1998), pp. 1136-1138
[58.]
J.L. Myers, A.A. Katzensteul.
Microangiitis in lupus-induced pulmonary hemorrhage.
Am J Clin Pathol, 85 (1986), pp. 552-556
[59.]
J.W. Leatruman, S.F. Davies, J.R. Hoidal.
Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders.
Medicine (Baltimore), 63 (1984), pp. 343-351
[60.]
G. Mintz, L.F. Galindo, J. Fernández-Díez, F.J. Jiménez, E. Robles-Saavedra, R.D. Enríquez-Casillas.
acute massive pulmonary hemorrhage in SLE.
J Rheumatol, 5 (1978), pp. 39-50
[61.]
R.P. Hillman, T.B. Cohen, A.I. Levinson, M.A. Kelley, M.L. Sachs.
SLE complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy.
J Rheumatol, 8 (1981), pp. 1021-1022
[62.]
C. Abud-Mendoza, E. Díaz-Jouanen, D. Alarcón-Segovia.
Fatal pulmonary hemorrhage in SLE. Occurrence without hemoptysis.
J Rheumatol, 12 (1985), pp. 558-561
[63.]
J.W. Eagen, V.A. Menoli, J.L. Roberts, G.R. Methews, M.M. Schwartz, E.I. Lewis.
Pulmonary hemorrhage in SLE.
Medicine (Baltimore), 57 (1978), pp. 545-560
[64.]
D.B. Gould, R.Z. Soriano.
acute alveolar hemorrhage in LE.
Ann Intern Med, 83 (1975), pp. 836-837
[65.]
E. Gertner.
Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment.
J Rheumatol, 26 (1999), pp. 805-807
[66.]
H.S. Howe, M.L. Boey, K.Y. Fong, P.H. Feng.
Pulmonary hemorrhage, pulmonary infarction, and the lupus anticoagulant.
Ann Rheum Dis, 47 (1988), pp. 869-872
[67.]
G. Hillerdal, A. Hagg, G. Licke, G. Wegenius, L. Scheibenpflug.
Intraalveolar haemorrhage in the anticardiolipin antibody syndrome.
Scand J Rheumatol, 20 (1991), pp. 58-62
[68.]
D.M. Aronoff, J.P. Callen.
Necrosing livedo reticularis in a patient with recurrent pulmonary hemorrhage.
J Am Acad Dermatol, 37 (1997), pp. 300-302
[69.]
F.J. Wiedermann, A. Mayr, W. Schobersberger, H. Knotzer, N. Sepp, M. Rieger, et al.
acute respiratory failure associated with catastrophic antiphospholipid syndrome.
J Intern Med, 247 (2000), pp. 723-730
[70.]
G.W. Waterer, B. Latham, J.A. Waring, E. Gabbay.
Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis.
Respirology, 4 (1999), pp. 405-408
[71.]
E.P. Schwab, J.r. Schumacher R, B. Freubdlich, P.E. Callegari.
Pulmonary alveolar hemorrhage in systemic lupus erythematosus.
Semin Arthritis Rheum, 23 (1993), pp. 8-15
[72.]
S.M. Greaves, E.M. Hart, K. Brown, D.A. Young, P. Batra, D.M. Aberle.
Pulmonary thromboembolism: spectrum of findings on CT.
Ajr, 165 (1995), pp. 1359-1363
[73.]
G. Hillerdal.
The lung physician and the antiphospholipid syndrome.
Eur Respir J, 10 (1997), pp. 511-512
[74.]
D.W. Branch, N.K. Kochenour, N.S. Rok, J.R. Scott.
A new postpartum syndrome associated with antiphospholipid antibodies.
Proc II Intl Symp Antiphospholipid Antibodies, (1986), pp. 10
[75.]
M.J. Kupferminc, M.J. Lee, D. Green, A.M. Peaceman.
Severe postpartum pulmonary, cardiac, and renal syndome associated with antiphospholipid antibodies.
Obstet Gynecol, 83 (1994), pp. 806-807
[76.]
H. Savin, M. Hoberman, E. Kott, M. Lishner, Y. Kitai, D. Kidron, et al.
Fibrosing alveolitis associated with primary antiphospholipid antibodies.
J Rheumatol, 33 (1994), pp. 977-980
[77.]
Kelion AD, Cockcroft JR, Ritter JM. Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
